Publications

Publications keep interested parties informed about the latest scientific, clinical, trial-based, and peer-reviewed documentation about our products and pipeline. Find the latest below:

sort by:

DIABETES CARE

2024;47(9):1682-1687

A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery

view publication

DIABETES THERAPY

2023; 14(3): 611-617

Time–Action Profile of Technosphere Insulin in Children with Type 1 Diabetes

view publication

Endocrine Practice

2021; 27(5): 449-454

Ultra Rapid-Acting Inhaled Insulin Improves Glucose Control in Patients With Type 2 Diabetes Mellitus

view publication

Clin. Drug Investigation.

2020; 40: 973–983

Comprehensive Pulmonary Safety Review of Inhaled Technosphere® Insulin in Patients with Diabetes Mellitus.

view publication

Diabet. Med.

2020; 37: 752–759

Hypoglycaemia is reduced with use of inhaled Technosphere® Insulin relative to insulin aspart in type 1 diabetes mellitus.

view publication

Diabetes Technol

Ther. 2018; 20(10): 639-647

Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.

view publication

J. Diabetes Sci. Technol.

2017; 11(1): 157–159

The Need for Faster Insulin: Problem Solved?

view publication

J. Diabetes Sci. Technol

2017; 11(1): 148–156

Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin.

view publication

CPT Pharmacometrics Syst. Pharmacol

2017; 6: 365-72

A Population Dose-Response Model for Inhaled Technosphere Insulin Administered to Healthy Subjects.

view publication

BMJ Open Diabetes Res. Care

2016; 4: e000228

Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled Insulin

view publication

Diabetes Technol. Ther

2016; 18(9): 574–585

Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator.

view publication

Diabetes Care

2015; 38(12): 2266-73

Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial.

view publication
<